These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3282029)

  • 21. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quality of life in patients with essential arterial hypertension. Part II: The effect of clinical factors].
    Klocek M; Kawecka-Jaszcz K
    Przegl Lek; 2003; 60(2):101-6. PubMed ID: 12939856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
    Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM; Baguet JP; Siché JP; Benkritly A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild hypertension: treat patients, not populations.
    Ramsay LE
    J Hypertens; 1985 Oct; 3(5):449-55. PubMed ID: 3905961
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
    Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B
    Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actual blood pressure control: are we doing things right?
    Coca A
    J Hypertens Suppl; 1998 Jan; 16(1):S45-51. PubMed ID: 9534097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive effect and safety evaluation of vegetable drink with peptides derived from sardine protein hydrolysates on mild hypertensive, high-normal and normal blood pressure subjects].
    Kawasaki T; Jun CJ; Fukushima Y; Kegai K; Seki E; Osajima K; Itoh K; Matsui T; Matsumoto K
    Fukuoka Igaku Zasshi; 2002 Oct; 93(10):208-18. PubMed ID: 12471719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)].
    Raveau-Landon C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1179-81. PubMed ID: 8572869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension in the elderly].
    Rahn KH
    Internist (Berl); 1993 Dec; 34(12):1090-5. PubMed ID: 8106204
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of hypertension in Italy: results of the "Study on Antihypertensive Treatment in General Practice (STAP)". Physicians Taking Part in STAP.
    Avanzini F; Alli C; Colombo P; Corsetti A; Colombo F; Tognoni G
    G Ital Cardiol; 1998 Jul; 28(7):760-6. PubMed ID: 9773300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y; Liu G; Jiang B; Gao R; Chen L; Su L; Li J
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of a new antihypertensive (guanabenz).
    McMahon FG; Cole PA; Boyles PW; Vanov SK
    Curr Ther Res Clin Exp; 1974 May; 16(5):389-97. PubMed ID: 4209126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.